We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

99 hedge funds and large institutions have $91M invested in iShares US Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

15% more capital invested

Capital invested by funds: $78.9M → $91M (+$12.1M)

8.28% more ownership

Funds ownership: 67.77% → 76.05% (+8.3%)

5% more funds holding

Funds holding: 94 → 99 (+5)

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
33
Reduced
21
Closed
12
Calls
$592K
Puts
–
Net Calls
+$592K
Net Calls Change
-$133K

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$5.93M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.93M
3
Wells Fargo
Wells Fargo
California
+$1.24M
4
LPL Financial
LPL Financial
California
+$988K
5
Bank of America
Bank of America
North Carolina
+$974K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.49M
2
CFGS
Concourse Financial Group Securities
Alabama
-$3.55M
3
DS
DRW Securities
Illinois
-$568K
4
CS
Candriam SCA
Luxembourg
-$294K
5
FWCM
Ferguson Wellman Capital Management
Oregon
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
26
Pinnacle Advisory Group
Maryland
$713K +$113K +1,974 +20%
AMG
27
Asset Management Group
Connecticut
$708K +$2.05K +36 +0.3%
TFF
28
The Family Firm
Maryland
$706K -$19K -333 -3%
Ameriprise
29
Ameriprise
Minnesota
$664K +$68.7K +1,206 +12%
RJFSA
30
Raymond James Financial Services Advisors
Florida
$650K -$1.71K -30 -0.3%
OPS
31
Orion Portfolio Solutions
Nebraska
$584K -$58.8K -1,032 -10%
JMPWA
32
JP Morgan Private Wealth Advisors
California
$496K +$73.4K +1,287 +18%
CFGS
33
Concourse Financial Group Securities
Alabama
$441K -$3.55M -62,340 -89%
JP Morgan Chase
34
JP Morgan Chase
New York
$415K +$51K +894 +15%
RMAM
35
Raab & Moskowitz Asset Management
New Jersey
$393K -$6.67K -117 -2%
CAN
36
Cetera Advisor Networks
California
$391K -$25.8K -453 -6%
OC
37
Oppenheimer & Co
New York
$386K – – –
Rockefeller Capital Management
38
Rockefeller Capital Management
New York
$377K +$342 +6 +0.1%
Creative Planning
39
Creative Planning
Kansas
$375K +$20K +351 +6%
Goldman Sachs
40
Goldman Sachs
New York
$359K – – –
ASN
41
Advisory Services Network
Georgia
$348K +$300K +5,262 +933%
Cetera Investment Advisers
42
Cetera Investment Advisers
Illinois
$318K +$303K +5,319 New
Cambridge Investment Research Advisors
43
Cambridge Investment Research Advisors
Iowa
$315K -$3.76K -66 -1%
KAS
44
Kestra Advisory Services
Texas
$312K +$299K +5,247 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$311K -$89.8K -1,575 -24%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$309K -$36.8K -645 -11%
BAM
47
Belpointe Asset Management
Nevada
$305K +$186K +3,264 +179%
PAG
48
Private Advisor Group
New Jersey
$272K +$171 +3 +0.1%
NFC
49
Northeast Financial Consultants
Connecticut
$248K – – –
CPSC
50
Carl P. Sherr & Co
Massachusetts
$220K – – –
1
2
3 4 5

IHE Hedge Fund Activity: Q4 2020 in Review

99 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2020, worth a combined $91M — up 15% from $78.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IHE positions and 12 closed out — a net gain of 6 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $5.93M. The largest seller was Susquehanna International Group, cutting an estimated $6.49M.

  • 99 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2020, up from 94 in Q3 2020.
  • Funds reported $91M of iShares US Pharmaceuticals ETF stock for Q4 2020, up 15% quarter-over-quarter.
  • 18 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2020 and 12 closed out, a net change of +6 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2020 was Tower Research Capital (TRC), an estimated $5.93M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2020 was Susquehanna International Group, an estimated $6.49M sold.

Based on aggregated 13F filings for Q4 2020.